JP2002505672A - 水溶液中における保護されていないか又はn−末端システインで保護されたペプチドの固相での自然化学連結 - Google Patents

水溶液中における保護されていないか又はn−末端システインで保護されたペプチドの固相での自然化学連結

Info

Publication number
JP2002505672A
JP2002505672A JP50326799A JP50326799A JP2002505672A JP 2002505672 A JP2002505672 A JP 2002505672A JP 50326799 A JP50326799 A JP 50326799A JP 50326799 A JP50326799 A JP 50326799A JP 2002505672 A JP2002505672 A JP 2002505672A
Authority
JP
Japan
Prior art keywords
peptide
solid phase
terminal
segment
unprotected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP50326799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002505672A5 (cg-RX-API-DMAC10.html
Inventor
キャン,ライン
ビー.エイチ. ケント,スティーブン
サイモン,レイナ
Original Assignee
グライフォン サイエンシズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グライフォン サイエンシズ filed Critical グライフォン サイエンシズ
Publication of JP2002505672A publication Critical patent/JP2002505672A/ja
Publication of JP2002505672A5 publication Critical patent/JP2002505672A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
    • C07K1/086—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/023—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution using racemisation inhibiting agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP50326799A 1997-06-13 1998-06-12 水溶液中における保護されていないか又はn−末端システインで保護されたペプチドの固相での自然化学連結 Ceased JP2002505672A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4955397P 1997-06-13 1997-06-13
US60/049,553 1997-06-13
PCT/US1998/012278 WO1998056807A1 (en) 1997-06-13 1998-06-12 Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution

Publications (2)

Publication Number Publication Date
JP2002505672A true JP2002505672A (ja) 2002-02-19
JP2002505672A5 JP2002505672A5 (cg-RX-API-DMAC10.html) 2005-12-22

Family

ID=21960431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50326799A Ceased JP2002505672A (ja) 1997-06-13 1998-06-12 水溶液中における保護されていないか又はn−末端システインで保護されたペプチドの固相での自然化学連結

Country Status (9)

Country Link
US (4) US6326468B1 (cg-RX-API-DMAC10.html)
EP (1) EP1001968B1 (cg-RX-API-DMAC10.html)
JP (1) JP2002505672A (cg-RX-API-DMAC10.html)
AT (2) ATE354584T1 (cg-RX-API-DMAC10.html)
AU (1) AU745094B2 (cg-RX-API-DMAC10.html)
CA (1) CA2292724A1 (cg-RX-API-DMAC10.html)
DE (2) DE69837170T2 (cg-RX-API-DMAC10.html)
ES (2) ES2235336T3 (cg-RX-API-DMAC10.html)
WO (1) WO1998056807A1 (cg-RX-API-DMAC10.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007046456A1 (ja) * 2005-10-19 2007-04-26 Chugai Seiyaku Kabushiki Kaisha 新規水溶性プロドラッグを含有する、膵臓癌、卵巣癌または肝臓癌の予防または治療剤
US7910593B2 (en) 2004-04-09 2011-03-22 Chugai Seiyaku Kabushiki Kaisha Water-soluble prodrugs
US8022047B2 (en) 2005-08-22 2011-09-20 Chugai Seiyaku Kabushiki Kaisha Combination anticancer agents
JP2014532075A (ja) * 2011-10-17 2014-12-04 サントル ナシオナル ドゥ ラ ルシェルシェサイアンティフィク(セエヌエールエス) タンパク質の合成方法
KR20210098466A (ko) * 2018-11-30 2021-08-10 가부시키가이샤 도우사 고가쿠 겐큐쇼 펩티드 티오에스테르 및 펩티드의 신규 제조 방법

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184344B1 (en) * 1995-05-04 2001-02-06 The Scripps Research Institute Synthesis of proteins by native chemical ligation
US6849428B1 (en) * 1997-03-05 2005-02-01 New England Biolabs, Inc. Intein-mediated protein ligation of expressed proteins
DE69837170T2 (de) * 1997-06-13 2007-11-22 Amylin Pharmaceuticals, Inc., San Diego Festphasige native chemische Ligation von ungeschützten oder n-cystein-geschützten Peptiden in wässrigen Lösungen
US6844161B2 (en) 1997-09-04 2005-01-18 Gryphon Therapeutics, Inc. Modular protein libraries and methods of preparation
AUPP589598A0 (en) 1998-09-14 1998-10-08 University Of Queensland, The Novel peptides
US7001745B1 (en) * 1998-09-30 2006-02-21 New England Biolabs, Inc. Intein mediated peptide ligation
EP1159289A1 (en) * 1999-03-11 2001-12-05 Gryphon Sciences Chemical synthesis and use of soluble membrane protein receptor domains
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
EP1307214A4 (en) * 2000-08-11 2006-01-18 Invitrogen Corp HIGHLY HOMOGENEOUS MOLECULAR MARKERS FOR ECTROPHORESIS
US20040014082A1 (en) * 2000-08-11 2004-01-22 Invitrogen Corporation Highly homogeneous molecular markers for electrophoresis
US6977292B2 (en) * 2000-09-01 2005-12-20 Gryphon Therapeutics Nucleophile-stable thioester generating compounds, methods of production and use
US7273923B2 (en) * 2001-01-22 2007-09-25 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
ATE346950T1 (de) * 2001-03-09 2006-12-15 Boston Probes Inc Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen
GB0113657D0 (en) * 2001-06-05 2001-07-25 Geneprot Inc Improved native chemical ligation with three or more components
EP2292273A3 (en) 2001-10-10 2011-11-23 BioGeneriX AG Remodeling and glycoconjugation of peptides
WO2003106615A2 (en) * 2002-06-10 2003-12-24 Geneprot, Inc. Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation
ATE312605T1 (de) * 2002-06-29 2005-12-15 Aquanova Ger Solubilisate Tech Isoflavonkonzentrate sowie verfahren zu ihrer herstellung
US7166574B2 (en) * 2002-08-20 2007-01-23 Biosurface Engineering Technologies, Inc. Synthetic heparin-binding growth factor analogs
US7598224B2 (en) 2002-08-20 2009-10-06 Biosurface Engineering Technologies, Inc. Dual chain synthetic heparin-binding growth factor analogs
US8227411B2 (en) 2002-08-20 2012-07-24 BioSurface Engineering Technologies, Incle FGF growth factor analogs
WO2004053460A2 (en) * 2002-12-11 2004-06-24 New England Biolabs, Inc. Carrier-ligand fusions and uses thereof
US8034900B2 (en) * 2002-12-30 2011-10-11 Amylin Pharmaceuticals, Inc. Water-soluble thioester and selenoester compounds and methods for making and using the same
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
SI1624891T2 (sl) * 2003-05-06 2013-09-30 Biogen Idec Hemophilia Inc. Strjevalni faktor-FC himerni proteini za zdravljenje hemofilije
WO2004105685A2 (en) * 2003-05-22 2004-12-09 Gryphon Therapeutics, Inc. Displaceable linker solid phase chemical ligation
US7414028B1 (en) 2004-02-04 2008-08-19 Biosurface Engineering Technologies, Inc. Growth factor analogs
US20080227696A1 (en) 2005-02-22 2008-09-18 Biosurface Engineering Technologies, Inc. Single branch heparin-binding growth factor analogs
US20060024347A1 (en) * 2004-02-10 2006-02-02 Biosurface Engineering Technologies, Inc. Bioactive peptide coatings
US7671012B2 (en) 2004-02-10 2010-03-02 Biosurface Engineering Technologies, Inc. Formulations and methods for delivery of growth factor analogs
US7528105B1 (en) 2004-02-10 2009-05-05 Biosurface Engineering Technologies Heterodimeric chain synthetic heparin-binding growth factor analogs
JP4895826B2 (ja) 2004-02-20 2012-03-14 バイオサーフェス エンジニアリング テクノロジーズ,インク. 骨形成蛋白−2の正のモジュレーター
EP1749022A2 (en) * 2004-05-24 2007-02-07 Rigel Pharmaceuticals, Inc. Methods for cyclizing synthetic polymers
KR20080003849A (ko) 2005-03-31 2008-01-08 아밀린 파마슈티칼스, 인크. 비만 및 섭식 장애의 조절, 예방 및 치료를 위한 조성물 및방법
US7674881B2 (en) * 2005-10-07 2010-03-09 The University Of Chicago Convergent synthesis of proteins by kinetically controlled ligation
US7820172B1 (en) 2006-06-01 2010-10-26 Biosurface Engineering Technologies, Inc. Laminin-derived multi-domain peptides
CA2692240C (en) 2006-06-22 2018-03-13 Biosurface Engineering Technologies, Inc. Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis
EP2120985B1 (en) 2007-02-05 2012-06-27 Amylin Pharmaceuticals, Inc. FN-38 peptides for use in the treatment of psychotic and anxiety disorders
WO2009032133A2 (en) * 2007-08-28 2009-03-12 Ipsen Pharma S.A.S. Methods and intermediates for chemical synthesis of polypeptides and proteins
EP2536287A4 (en) * 2010-02-18 2015-10-07 Advanced Proteome Therapeutics Inc SPECIFIC SITE SIZE OF PROTEINS USING CHEMICAL MODIFICATION TO PROMOTE PROTEIN CONJUGATE FORMATION, PROTEIN DIMER FORMATION, AND AGRAFTED PEPTIDES
MX349054B (es) 2010-09-28 2017-07-07 Aegerion Pharmaceuticals Inc Leptinas altamente solubles.
BR112013007442A2 (pt) 2010-09-28 2019-09-24 Amylin Pharmaceuticals Llc polipeptídeos construídos tendo duração de ação realçada
DK2729160T3 (da) 2011-07-08 2019-07-01 Aegerion Pharmaceuticals Inc Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet
JP6006309B2 (ja) 2011-07-08 2016-10-12 アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
US9545449B2 (en) 2012-05-11 2017-01-17 Advanced Proteone Therapeutics Inc. Site-specific labeling and targeted delivery of proteins for the treatment of cancer
WO2013177231A1 (en) 2012-05-21 2013-11-28 Massachusetts Institute Of Technology Translocation of non-natural chemical entities through anthrax protective antigen pore
SG11201505926VA (en) 2013-03-15 2015-09-29 Biogen Ma Inc Factor ix polypeptide formulations
US11273176B2 (en) 2016-03-02 2022-03-15 The Brigham And Women's Hospital, Inc. Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation
EP3590951A4 (en) * 2017-03-02 2021-01-06 Glytech, Inc. PROCESS FOR PRODUCING AN AMINO ACID POLYMER
KR20210072021A (ko) 2018-10-01 2021-06-16 유니베르시떼 드 제네브 생물학 분석에 적합한 복수의 폴리펩티드 변이체의 생산 방법
AU2020361681A1 (en) 2019-10-10 2022-05-05 1859, Inc. Methods and systems for microfluidic screening
US20210230218A1 (en) * 2019-10-23 2021-07-29 Mabplex International, Ltd. Oligopeptide linker intermediate and preparation method thereof
WO2022266467A2 (en) 2021-06-17 2022-12-22 Dana-Farber Cancer Institute, Inc. Recombinant histone polypeptide and uses thereof
WO2024146707A1 (en) 2023-01-06 2024-07-11 Université De Genève Variant ligand conjugates for payload delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064940A (en) * 1988-05-11 1991-11-12 Protein Technologies, Inc. Premixed dry reagent containing a protected amino acid and an activating agent for use in solid phase protein synthesis
US5101059A (en) * 1989-12-05 1992-03-31 Research Corporation Technologies, Inc. Amino acid protecting groups
DK0832096T3 (da) * 1995-05-04 2001-10-01 Scripps Research Inst Syntese af proteiner ved nativ kemisk ligering
JP4358307B2 (ja) * 1996-12-24 2009-11-04 ザ スクリップス リサーチ インスティテュート 一般的化学結合
DE69837170T2 (de) * 1997-06-13 2007-11-22 Amylin Pharmaceuticals, Inc., San Diego Festphasige native chemische Ligation von ungeschützten oder n-cystein-geschützten Peptiden in wässrigen Lösungen
US6329468B1 (en) * 2000-01-21 2001-12-11 Bostik Findley, Inc. Hot melt adhesive based on semicrystalline flexible polyolefins

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910593B2 (en) 2004-04-09 2011-03-22 Chugai Seiyaku Kabushiki Kaisha Water-soluble prodrugs
US8022047B2 (en) 2005-08-22 2011-09-20 Chugai Seiyaku Kabushiki Kaisha Combination anticancer agents
WO2007046456A1 (ja) * 2005-10-19 2007-04-26 Chugai Seiyaku Kabushiki Kaisha 新規水溶性プロドラッグを含有する、膵臓癌、卵巣癌または肝臓癌の予防または治療剤
JP2014532075A (ja) * 2011-10-17 2014-12-04 サントル ナシオナル ドゥ ラ ルシェルシェサイアンティフィク(セエヌエールエス) タンパク質の合成方法
KR20210098466A (ko) * 2018-11-30 2021-08-10 가부시키가이샤 도우사 고가쿠 겐큐쇼 펩티드 티오에스테르 및 펩티드의 신규 제조 방법
KR102769851B1 (ko) * 2018-11-30 2025-02-20 가부시키가이샤 도우사 고가쿠 겐큐쇼 펩티드 티오에스테르 및 펩티드의 신규 제조 방법

Also Published As

Publication number Publication date
DE69837170T2 (de) 2007-11-22
DE69837170D1 (de) 2007-04-05
ATE285415T1 (de) 2005-01-15
AU8069598A (en) 1998-12-30
ES2235336T3 (es) 2005-07-01
WO1998056807A1 (en) 1998-12-17
US20020132975A1 (en) 2002-09-19
US7094871B2 (en) 2006-08-22
ATE354584T1 (de) 2007-03-15
AU745094B2 (en) 2002-03-14
US20050209440A1 (en) 2005-09-22
DE69828287D1 (de) 2005-01-27
CA2292724A1 (en) 1998-12-17
EP1001968A1 (en) 2000-05-24
US20020169282A1 (en) 2002-11-14
ES2282788T3 (es) 2007-10-16
EP1001968B1 (en) 2004-12-22
US6326468B1 (en) 2001-12-04
DE69828287T2 (de) 2005-12-15
US7030217B2 (en) 2006-04-18

Similar Documents

Publication Publication Date Title
EP1001968B1 (en) Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution
EP1392718B1 (en) Improved native chemical ligation with three or more components
US4786684A (en) Benzylthioether-linked solid support-bound thiol compounds and method for peptide synthesis
CZ80399A3 (cs) Způsob výroby peptidů
JP2001507027A (ja) 一般的化学結合
JP4399627B2 (ja) 3つまたはそれ以上の成分による化学ペプチド連結
JPH0632790A (ja) ビオチン導入試薬およびそれを用いる合成ペプチド精製法
RU2182155C2 (ru) Получение очищенных (поли)пептидов
WO2004105685A2 (en) Displaceable linker solid phase chemical ligation
Whitney et al. A new base-catalyzed cleavage reaction for the preparation of protected peptides
EP1518862B1 (en) Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution
JP2005529188A (ja) オリゴペプチドの化学連結における酸性c末端アミノ酸についてのカルボキシ保護ストラテジー
JP2010537984A (ja) ポリペプチドおよび蛋白質の化学合成のための方法および中間体
JP2018145151A (ja) 多機能型ペプチドプローブ及びこれを用いた標的分子の選択的濃縮法
JP2777193B2 (ja) ペプチドの製造方法
WO2007043615A1 (ja) ペプチドエステル試薬、およびそのライゲーションまたはチオエステル化合物の製造のための使用
JPH0297398A (ja) 固相ペプチド合成におけるpam酵素の使用
CN113264979A (zh) 可脱除骨架修饰快速脱除的新方法及应用
AU2002319850A1 (en) Improved native chemical ligation with three or more components
Maguire Novel protecting group strategies for the aspartyl residue in peptide synthesis
Bianchi et al. Engineering and chemical synthesis of the HCV protease transmembrane protein cofactor NS4A
BURTON PEPTIDE SEMISYNTHESIS WITH UNBLOCKED BETA (PORCINE)-MSH
AU2002363612A1 (en) Extended native chemical ligation of three or more peptide fragments

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080304

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20080722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080930